Founder and Chief Executive Officer
Kathy Giusti is the Founder and Chief Executive Officer of the Multiple Myeloma Research Foundation (MMRF) and the Multiple Myeloma Research Consortium (MMRC). Giusti launched the MMRF in 1998, after her diagnosis with the incurable blood cancer multiple myeloma, followed by the MMRC in 2004. Leveraging her for-profit experience, she applied her business savvy to the science of cancer research and has helped to transform the culture of the traditional not-for-profit model. Her successful track record of building groundbreaking collaborative models underpinned by strong incentive structures to accelerate drug discovery and development has yielded meaningful returns for multiple myeloma patients. Further, committed to maximizing the patient-impact of these models, Giusti has shared her approach with many research organizations that are pursuing treatment advances for a number of cancers and other devastating diseases. Prior to founding the MMRF, Giusti, a former pharmaceutical executive who began her career with Merck & Co, last served as Executive Director of G.D. Searle’s worldwide arthritis franchise. Giusti, a multiple myeloma patient, was named to the 2011 TIME 100 List of the world’s most influential people. She has received many other awards for her leadership efforts, including the American Association for Cancer Research (AACR) Centennial Medal for Distinguished Public Service, the Harvard Business School Alumni Achievement Award, and the Healthcare Businesswomen's Association's Woman of the Year Award. Additionally, she has been featured on the Today Show, CBS Evening News, CBS This Morning, CNN Money, Fox News and NBC Nightly News, as well as in The Wall Street Journal, The New York Times, The Economist, and TIME. Giusti currently serves on the President's Council of Advisors on Science and Technology, as an advisor to Stand Up to Cancer, and has previously served on the President’s National Cancer Advisory Board, the Board of Directors for IMS Health, and the Institute of Medicine's National Cancer Policy Board. She received her MBA in general management from Harvard Business School and graduated from the University of Vermont magna cum laude with a Bachelor of Science in Biological Sciences.
Walter M Capone
President Multiple Myeloma Research Foundation
Walter Capone oversees the core business operations of the MMRF and as part of the Executive Committee executes the growth initiatives outlined in the organization’s strategic plan. He has 20 years of pharmaceutical and biotechnology leadership experience in the areas of Commercial Development, Operations, Finance, Marketing and Sales in the United States and internationally. Prior to joining the MMRF, he was the Vice President of Commercial Development and Operations at Progenics Pharmaceuticals. He previously worked at a number of entrepreneurial pharmaceutical and biotechnology ventures throughout the United States and Europe including Trimeris, Triangle Pharmaceuticals and Cyanamid Benelux. He started his career at leading global pharmaceutical companies including Lederle, Wyeth and Bristol-Myers Squibb. He received his BA in International Relations from Brown University and he has an MBA in Finance and International Business from Columbia University Business School.
Beverly L Harrison
Vice President of Clinical Development Multiple Myeloma Research Foundation
Beverly Harrison is Vice President of Clinical Development of the MMRC. Ms Harrison is a seasoned research and development executive with more than 20 years of experience in both pharmaceutical and contract research organizations (CROs). Her areas of expertise include domestic and international operations, business development, sales and marketing management, strategic planning, and change management. Prior to joining the MMRC, Ms Harrison played a pivotal role in sales and marketing turnaround for three CROs in late- and early-stage services, co-founded her own niche oncology-focused CRO business with a physician and a business partner, and provided general management leadership for late-stage services for a global CRO. Ms Harrison graduated from the College of William and Mary in Williamsburg, Virginia, with a Bachelor of Science.
Anne Quinn Young, MPH
Vice President, Strategic Alliances Multiple Myeloma Research Foundation
Anne Quinn Young, MPH, is Vice President of Strategic Alliances at the MMRF, where she oversees all communications as well as educational programming for and outreach to healthcare professionals and patients. Ms Young currently serves as the MMRF's representative on the Cancer Leadership Council (CLC) and as principal investigator on a major grant from the Centers for Disease Control and Prevention (CDC). Prior to joining the MMRF, she was a consultant in the Healthcare Practice of Datamonitor, a global market research and business intelligence company. She previously worked in healthcare public relations at Burson-Marsteller and Chandler Chicco Agency, following a postgraduate internship at the Department of Justice, Antitrust Division. Ms Young has a Master of Public Health from the Mailman School of Public Health of Columbia University and graduated cum laude from Dartmouth College with a Bachelor of Arts in Government.
Viewing 1 - 4 of 4